KFDA set to extend validation waiver for GMP

Published: 2007-07-05 06:57:00

Updated: 2007-07-05 06:57:00

The Korea Food and Drug Administration is expected to support a plan to recognize the conventional drugs whose GMP (Good Manufacturing Practice) validation was fulfilled based on the in-house regulations of pharmaceutical drug manufacturers.

In a meeting with representatives from drug makers ...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK